A PIPELINE POWERED BYPASSION
PUBLICATIONS AND PRESENTATIONS
CV Outcomes Trial for Omecamtiv Mecarbil Enrolls 8,256 Patients With HFrEF
Poster, American College of Cardiology & World Congress of Cardiology 2020 (ACC.20/WCC)
Virtual Online
March 28, 2020
The novel myotrope, AMG 594, is a small-molecule cardiac troponin activator that increases cardiac contractility in vitro and in vivo
Poster, Keystone Symposium: Charting a New Course for Heart Failure: From Discovery to Data
Keystone, Colorado
March 3, 2020
Characterization of the Cardiac Myosin Inhibitor CK-3773274: a Potential Therapeutic Approach for Hypertrophic Cardiomyopathy
Poster, Biophysical Society 64th Annual Meeting
San Diego, California
February 19, 2020
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF
JACC: Heart Failure
Teerlink JR, Diaz R, Felker M, McMurrary John JV, Metra M, Solomon SD, Legg JC, Buchele G, Varin C, Kurtz CE, Malik FI, Honarpour N
February 5, 2020
Responder and Subgroup Analyses for FORTITUDE-ALS, a Phase 2 Trial of Reldesemtiv in Patients with ALS
Poster, 30th International Symposium on ALS/MND
Perth, Australia
December 5, 2019